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a b s t r a c t
Rift Valley fever virus (RVFV) infection is often associated with pronounced liver damage. Previously, our
studies revealed altered host phospho-signaling responses (NFκB, MAPK and DNA damage responses) in
RVFV infected epithelial cells that correlated with a cellular stress response. Here, we report that RVFV
infection of liver cells leads to an increase in reactive oxygen species (ROS). Our data suggests the
presence of the viral protein NSs in the mitochondria of infected cells, hence contributing to early
increase in ROS. Increased ROS levels correlated with activation of NFκB (p65) and p53 responses, which
in conjunction with infection, was also reﬂected as macromolecular rearrangements observed using size
fractionation of protein lysates. Additionally, we documented an increase in cytokine expression and pro-
apoptotic gene expression with infection, which was reversed with antioxidant treatment. Collectively,
we identiﬁed ROS and oxidative stress as critical contributors to apoptosis of liver cells during RVFV
infection.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Rift Valley fever virus (RVFV) is an arbovirus belonging to the
genus Phlebovirus, family Bunyaviridae (Ikegami and Makino, 2011;
Weaver and Reisen, 2010; Bouloy and Weber, 2010; Ikegami, 2012).
The viral genome is a single stranded RNA, which exists as three
segments namely, large (L), medium (M) and small (S) (Terasaki et al.,
2011; Gauliard et al., 2006; Ikegami et al., 2005a, 2005b). The L
segment codes for the viral RNA dependent RNA polymerase. The M
segment codes for the two structural proteins Gn and Gc and two
nonstructural proteins, 78 kDa protein and NSm. The S segment
codes for the N protein and the nonstructural protein NSs. NSs plays
an essential role in the viral life cycle by down regulating the host
innate immune response early in infection (Kalveram et al., 2011,
2013; Benferhat et al., 2012; Mansuroglu et al., 2010; Ikegami et al.,
2009a, 2009b; Habjan et al., 2009; Le May et al., 2008). NSm protein
has been demonstrated to have an anti-apoptotic function in infected
cells (Won et al., 2007).
RVFV is mainly transmitted by mosquitoes, although other
arthropods including ﬂies have also been demonstrated to be
adequate hosts (Amraoui et al., 2012; Turell et al., 2008, 2010a,
2010b; Seuﬁ and Galal, 2010). Viral infection of humans results in
Rift Valley Fever (RVF) with ﬂu-like symptoms (Ikegami and
Makino, 2011). RVFV infections are often accompanied by liver
damage. In a small percentage of cases, RVF can result in
hemorrhage and neuronal phenotypes. Viral infection of livestock
results in abortion rates that can reach 100% and high fatality
among newborns (Ikegami and Makino, 2011; Bouloy and Weber,
2010). RVFV is classiﬁed as a category A select agent, an emerging
infectious agent and an agricultural pathogen. The currently
available vaccine candidates include mutant viruses (deleted for
NSs, NSm segments), vaccines based on structural proteins, recon-
structed virions, viral replicon particles or serially passaged
attenuated virus (Bird et al., 2011; Kortekaas et al., 2012; Dodd
et al., 2012; Kalveram et al., 2011; Jansen van Vuren et al., 2011;
Morrill and Peters, 2011; Pichlmair et al., 2010; de Boer et al., 2010;
Mandell et al., 2010; Ikegami and Makino, 2009). These candidates
however, have not yet been approved for human use.
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
0042-6822/$ - see front matter & 2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.virol.2013.11.023
n Correspondence to: National Center for Biodefense and Infectious Diseases,
George Mason University, Discovery Hall, Room 182, 10900 University Blvd,
MS 1H8, Manassas, VA, USA. Tel. þ1 703 993 9160, fax: þ1 703 993 7022.
E-mail address: fkashanc@gmu.edu (F. Kashanchi).
1 Contributed equally.
Virology 449 (2014) 270–286
Interactions between the virus and its host have been subject to
intense investigation by multiple laboratories as this can provide
critical information for the development of novel diagnostic and
therapeutic avenues. Our previous approaches to understand
host–pathogen interactions of RVFV and its human host using
Reverse Phase Protein MicroArray (RPMA) have yielded signiﬁcant
information about host responses in infected cells (Popova et al.,
2010). We have shown that RVFV infection of human cells induced
multiple shifts in the anti- and pro-apoptotic pathways at early
and late stages of infection. RVFV infection resulted in activation of
stress responses and DNA damage responses (DDR) (Narayanan
et al., 2011; Baer et al., 2012). Additionally, RVFV infection induced
activation of critical transcription factors including NFκB (p65) and
p53 (Narayanan et al., 2012; Austin et al., 2012). Our laboratory
and those of our colleagues have demonstrated that inhibition of
host responses during RVFV infection is a viable method to inhibit
viral multiplication and afford protection to the host (Popova et al.,
2010; Baer et al., 2012; Narayanan et al., 2012; Moser et al., 2012;
Filone et al., 2010).
Studies with animal model systems have demonstrated that
RVFV infection induces apoptotic responses in the liver of infected
animals (Smith et al., 2010, 2012; Reed et al., 2012; Ding et al.,
2005). Notably, strong inﬂammatory responses including cytokine
secretion have been indicated to be involved in the apoptotic
outcome in infected livers. Oxidative stress following infection is a
key component that inﬂuences disease outcome in the host in the
case of multiple viral infections including Hepatitis B virus (HBV),
Hepatitis C virus (HCV), Human Immunodeﬁciency Virus (HIV),
and Crimean Congo Hemorrhagic Fever virus (CCHF) (Duygu et al.,
2012; Tawadrous et al., 2012; Lin et al., 2011; Rodrigues et al.,
2012). Many viral proteins have been demonstrated to actively
modulate the host oxidative stress responses to facilitate replica-
tion. For example, the viral core protein of HCV was shown to
increase oxidative stress in HepG2 cells by interfering with the
heme oxygenase mediated host response (Abdalla et al., 2012).
HCV proteins including E1 and E2 were demonstrated to activate
the antioxidant defense Nrf2/ARE pathway via several indepen-
dent mechanisms (Ivanov et al., 2011). HCV nonstructural proteins
contribute to pathogenesis by inﬂuencing mitochondrial redox
potential ending in mitochondrial injury and apoptosis in liver
cells (Abdalla et al., 2005; Gong et al., 2001). Use of antioxidants
has had beneﬁcial effects in HCV patients by attenuating multiple
oxidative stress induced responses (Farias et al., 2012).
Reactive oxygen species (ROS) is an important host component
that contributes to the innate immune response against multiple
pathogens. ROS production may directly inﬂuence pathogen killing
as seen in the case of infected macrophages (Jaeschke, 2011). ROS
are also secondary signaling messengers that activate many host
phospho-signaling responses including the nuclear factor kappa
beta (NFkB), activating protein-1 (AP-1), mitogen-activating pro-
tein kinase (MAPK), phosphotidyl inositol-3 kinase (PI3K) and DNA
damage response (DDR) pathways (Waris et al., 2001; Gwinn and
Vallyathan 2006; Yang et al., 2010; Imai et al., 2008). Activation of
transcription factors such as p65 and p53 due to increased
intracellular ROS contributes to the inﬂammatory responses such
as cytokine secretion.
In this manuscript, we have investigated the early onset of
oxidative stress that leads to apoptotic responses in RVFV-infected
liver cells. Our working hypothesis was that RVFV infection-
induced oxidative stress activated both p65 and p53, which in
turn modulated cytokine secretion and apoptotic gene expression
proﬁles leading to cell death. Therefore, amelioration of oxidative
stress in infected cells using antioxidants would decrease inﬂam-
matory cytokine expression, and apoptotic gene expression. Our
data indicate that p65 activation occurred early in the temporal
sequence of events after RVFV infection while p53 activation
occurred at later time points. Antioxidants down regulated expres-
sion of inﬂammatory cytokines and apoptotic gene expression in
liver cells. Therefore, antioxidants warrant further examination as
a potential therapeutic strategy to achieve hepatoprotection in
RVFV infections.
Results
HepG2 cells display increased reactive oxygen species following RVFV
infection
We had demonstrated in our earlier studies that RVFV infection
of epithelial cells resulted in increased expression of superoxide
dismutase, an enzyme that is involved in oxidative stress response
(Narayanan et al., 2011). The liver is one of the most prominently
affected organs during RVFV infection. Oxidative stress has been
demonstrated to play a critical role in liver pathologies both in the
case of cancer and in virus infections such as HCV (Tawadrous
et al., 2012). In many of these pathological responses in the liver,
the outcome was associated with the host inﬂammatory responses
including production of cytokines and resultant apoptosis (Duygu
et al., 2012; Tawadrous et al., 2012; Lin et al., 2011). Therefore, we
attempted to analyze oxidative stress and associated cytokine
responses in RVFV infected liver cells. We ﬁrst examined the
generation of ROS in RVFV infected HepG2 cells following infec-
tion. HepG2 cells were infected with the MP-12 strain of RVFV,
ﬁxed and stained using MitoSox stain at 3 h post infection.
Fig. 1. Increased ROS in RVFV infected HepG2 cells. (A) HepG2 cells were infected with the MP-12 strain of RVFV (MOI: 3) and stained after 3 h using MitoSox stain and DAPI.
The stained cells were visualized by confocal microscopy. (B) HepG2 cells infected with MP-12 (MOI: 3) were lysed at 24 h post infection and total protein lysate obtained.
Lysates from uninfected cells were obtained as controls and both lysates were resolved by SDS-PAGE and western blots, carried out using anti-RVFV and anti-β-actin
antibodies.
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MitoSox is a ﬂuorescent probe that is employed to measure
superoxide in cells and therefore can be utilized to analyze the
general superoxide content of the cell (Narayanan et al., 2011).
Upon MitoSox staining of HepG2 cells that were either mock
infected or infected with MP-12, we observed an increase in
superoxide levels in the infected cells (Fig. 1A). Quantiﬁcation of
the ﬂuorescence revealed an approximate 6-fold increase in
superoxide levels in virus-infected cells over the mock-infected
controls. Western blots were performed to detect expression of
viral proteins (glycoprotein) in infected cells to validate infection
and viral multiplication (Fig. 1B).
We then asked if the viral nonstructural proteins NSs and NSm
played a role in the generation of superoxide species at early and
late stages of infection. We infected HepG2 cells with either the
wild type virus (MP-12) or deletion mutants (MP-12ΔNSs; MP-
12ΔNSm) and MitoSox-stained ﬁxed cells at early (6 h post
infection) and late (24 h post infection) time points. These mutant
viruses do not display any signiﬁcant differences in replication
Fig. 2. NSs protein inﬂuences early stages of ROS accumulation in infected HepG2 cells. (A) and (C) HepG2 cells were infected with MP-12, MP-12ΔNSs and MP-12ΔNSm
virus strains (MOI: 3) and stained after 6 h and 24 h respectively using MitoSox stain and DAPI. Images of stained cells were obtained by confocal microscopy. (B) and (D) Fold
changes in mean ﬂuorescence intensities (MFIs) were obtained by comparing ﬂuorescence intensities of 10 randomly chosen ﬁelds of MP-12, MP-12ΔNSs and MP-12ΔNSm
infected cells (n475 cells). (E) HepG2 cells were infected with either recombinant MP-12 (rMP-12) or MP-12ΔNSs (MOI: 3) and supernatants collected at 4, 8 and 16 h post
infection. Supernatants were used to perform plaque assays as described in the materials and methods section. Results are represented graphically as replication kinetics of
rMP-12 and MP-12ΔNSs. The average number of PFU/mL is tabulated below and shows the average of three biological replicates plated in technical duplicates. Error bars
indicate the standard deviation for all 6 data points across the triplicate sample groups.
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kinetics compared to the parental MP-12 strain (Won et al., 2007;
Narayanan et al., 2012). The experiment revealed that at 6 h post
infection, the NSs deletion virus resulted in lower levels of super-
oxide species in the infected cells when compared to the wild type
virus or the NSm mutant (Fig. 2A) and quantiﬁcation of Mean
Fluorescence Intensity for ﬁelds of cells (MFI) revealed a statisti-
cally signiﬁcant decrease (Fig. 2B). To calculate fold changes in
MFIs, we compared ﬂuorescent intensities of 10 randomly chosen
ﬁelds of MP-12, MP-12ΔNSs and MP-12ΔNSm infected cells
(n475 cells).
Interestingly, when we analyzed cells at later time points (24 h
post infection), we did not observe statistically signiﬁcant differ-
ences in intracellular superoxide levels of cells infected with either
the wild type or the mutant viruses (Fig. 2C and D). We observed
that at early time points after infection, superoxide species were
largely restricted to the cytoplasm while at later time points, we
detected superoxide species inside the nucleus as well (Fig. 2C).
Nuclear accumulation of superoxide species may be indicative of a
wide spread disruption of homeostasis and the cellular oxidative
response machinery at later time points in RVFV-infected liver
cells. Viral infections of hepatocytes such as HCV have demon-
strated to increase perinuclear ROS levels, primarily involving
deregulated host antioxidant machinery including NADPH oxi-
dases (Beckman and Koppenol, 1996; Ushio-Fukai, 2009). Next, we
asked whether differences in early MitoSox staining, and hence
levels of superoxide species, between MP-12 and MP-12ΔNSs
could be a result of differences in replication kinetics between
the two viral strains. We performed plaque assays to quantify
replication kinetics of both viruses in HepG2 cells and the results
suggested that the two viral strains did not differ appreciably in
their replication (Fig. 2E).
We then asked if the observed phenotype of early NSs-
dependent accumulation of superoxide in infected cells could be
inﬂuenced by interferon. Interferon regulation is an important
aspect of NSs function in RVFV infection. To that end, we used Vero
cells, which are known to be deﬁcient in interferon production.
We infected Vero cells with MP-12, UV-inactivated MP-12, and
MP-12ΔNSs viruses. Mock-infected cells were maintained as
controls. The infected cells were stained with MitoSox at an early
time point and visualized for accumulation of superoxide species.
As shown in Fig. 3A, the accumulation of superoxide was max-
imum in MP-12 infected cells similar to what we had observed in
HepG2 cells. Evaluation of replication kinetics of MP-12 and MP-
12ΔNSs in the Vero cell line did not reveal any major difference
between the two strains (Fig. 3B).
Cumulatively, our studies reveal that RVFV infection of liver
cells results in a signiﬁcant increase in intracellular ROS levels
after infection. Furthermore, results suggest that while the viral
protein NSs may play a role in the onset of oxidative stress at early
time points after infection, the onset of oxidative stress in infected
cells at later time points was independent of NSs.
The viral protein NSs is associated with the mitochondria in RVFV-
infected liver cells
Our observation that infection by the NSs mutant virus resulted
in a statistically signiﬁcant decrease in ROS production in the
infected cells at early time points prompted the question of
whether NSs itself was associated with the mitochondria of
infected cells. The mitochondria are the primary organelles that
contribute to intracellular ROS levels as a part of the normal
cellular respiratory process. Deregulation of the mitochondrial
respiratory chain is observed during multiple disease states that
leads to ROS mediated pathology. Although nuclear functions of
NSs have been well documented, approximately 50% of the NSs
protein expressed in an infected cell is cytoplasmic at early hours
(Kehn Hall, personal communication). To determine if NSs dis-
played an association with the mitochondria in infected cells, we
infected HepG2 cells with a Flag-tagged NSs (Flag-NSs-MP-12)
containing virus. The infected cells were lysed and NSs immuno-
precipitated with an antibody against the Flag tag. The immuno-
precipitated material was directly processed for LC-MS/MS
analysis where the proteins were eluted from protein A/G beads
by 8M Urea and trypsinized. LC-MS/MS analysis of the trypsinized
Fig. 3. Increased ROS in MP-12 infected Vero cells. (A) Vero cells were mock infected or infected with MP-12, UV-MP-12 and MP-12ΔNSs (MOI: 3) and stained after 3 h using
MitoSox stain and DAPI. Images of stained cells were obtained by confocal microscopy. (B) Vero cells were infected with either recombinant MP-12 or MP-12ΔNSs (MOI: 3)
and supernatants collected at 4, 8 and 20 h post infection. Supernatants were used to perform plaque assays as described in the materials and methods section. The graph
represents the replication kinetics of rMP-12 and MP-12ΔNSs. The average number of PFU/mL is tabulated below and shows the average of three biological replicates plated
in technical duplicates. Error bars indicate the standard deviation for all 6 data points across the triplicate sample groups.
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peptides identiﬁed about 183 proteins that were distinct from
the IgG control immunoprecipitation. The 183 proteins covered a
wide range of cytoplasmic proteins including metabolic enzymes,
cytoskeletal proteins, chaperones, translational proteins including
ribosomal components in addition to about 23 proteins that were
associated with maintenance of oxidative homeostasis (Fig. 4A,
Supplemental Table). We also observed a limited set of nuclear
proteins including chromosome maintenance complex proteins,
nuclear phosphoprotein, ras-related nuclear protein, RAN binding
protein, nucleophosmin and nucleolin (Supplemental Table). The
cytoplasmic components were in excess in this case because we
had performed the immunoprecipitation with total protein lysates
without enriching for nuclear proteins. Our focus was on the
association of NSs with oxidative metabolism and we observed
that many proteins including members of the mitochondrial F0
and F1 complex co-precipitated with the Flag-tagged NSs as
shown by MS results. Next, we isolated mitochondria to determine
if NSs can be detected in the mitochondrial fraction of infected
cells at early time points. HepG2 cells were infected with the Flag-
NSs-MP-12 virus and crude mitochondrial extracts were prepared
at approximately 6 h post infection. The mitochondrial prepara-
tions were then lysed and western blots carried out using anti-
bodies to the Flag tag and cytochrome C, a mitochondrial marker
protein (Fig. 4B). Cytoplasmic fractions of the same preparations
were run alongside as controls. Results demonstrated the inclusion
of Flag-NSs in the mitochondrial fraction (Fig. 4B, lane 4) of Flag-
NSs-MP-12 infected cells. Cytochrome C was detected in both
mock-infected and Flag-NSs-MP-12-infected mitochondria (lanes
3, 4) as expected. Finally, β-actin was probed as a control and
observed in all samples. Therefore, our results suggest that the
viral protein NSs may be included in the mitochondria of infected
cells at earlier time points after infection which may contribute to
the NSs-dependent oxidative stress phenotype at early time
frames.
To further elucidate the relationship of NSs with the host
mitochondria we performed confocal microscopy. Brieﬂy, HepG2
cells were transfected with FLAG_NSs, ﬁxed after 6 h and stained
with antibodies against the FLAG tag and mitochondria. Fig. 5A
shows representative images of HepG2 cells positive for FLAG_NSs
and displaying co-localization with mitochondria. In Fig. 5A, we
demonstrate the colocalization of NSs with the mitochondria as
observed in a Z-stack section of the image in the last panel
(expanded inset). A total of 211 cells were visualized and counted
of which 128 were positive for FLAG_NSs. Of the 128 cells, 44 cells
showed co-localization of the FLAG_NSs and the mitochondria (as
inferred by the yellow staining pattern). Additional examples of
colocalization of NSs and mitochondria in infected HepG2 cells are
shown in Fig. 5B. We also conﬁrmed expression of FLAG-NSs at the
6 h time point by performing a western blot for FLAG-NSs in
infected cells. The data shown in Fig. 5C indicates that FLAG-NSs
could be detected in these cells at the 6 h time point. Finally, we
asked the question whether NSs, by itself, out of context of a viral
infection would localize to the mitochondria. To answer that
question, we transfected a plasmid encoding FLAG-NSs into HepG2
cells. Twenty-four hours post transfection, the cells were ﬁxed and
stained with anti-FLAG and anti-mitochondria antibodies and
observed by confocal microscopy. NSs showed a diffuse nuclear
staining and no distinct ﬁlaments could be detected as in the case
Reference P (pro) Score MW Accession
Scan(s) P (pep) XC Sp RSp
glucose phosphate isomerase 5.55E-15 30.22 63107.3 18201905
glyceraldehyde-3-phosphate dehydrogenase 7.77E-15 90.27 36030.4 7669492
glutathione transferase 4.88E-14 30.25 23341.0 4504183
transketolase isoform 1 1.13E-11 60.22 67834.9 4507521
mitochondrial ATP synthase beta subunit precursor 1.50E-11 20.19 56524.7 32189394
mitochondrial malate dehydrogenase precursor 2.09E-11 20.22 35480.7 21735621
aldo-keto reductase family 1, member B10-like 1.39E-10 20.20 36513.8 122937516
aldehyde dehydrogenase 1A1 1.48E-10 70.23 54827.0 21361176
aldo-keto reductase family 1, member B10 1.71E-10 50.22 35996.9 223468663
triosephosphate isomerase 1 isoform 1 3.56E-10 60.21 26652.7 4507645
glutathione reductase 8.98E-10 10.14 56221.0 50301238
solute carrier family 25 (mitochondrial carrier), member 31 8.67E-10 10.18 34999.4 13775208
translocase of inner mitochondrial membrane 50 homolog 8.74E-09 10.18 50433.2 48526509
ATP synthase, H+ transporting, mitochondrial F1 complex 1.98E-08 30.16 59713.7 4757810
acyl-Coenzyme A oxidase 1 isoform a 8.92E-08 10.16 74620.2 30089972
glucose-6-phosphate dehydrogenase isoform b 9.02E-08 50.18 59219.1 108773793
aldo-keto reductase family 1, member C2 1.04E-07 30.20 36712.0 4503285
NAD(P)H menadione oxidoreductase 1, isoform a 2.65E-07 40.18 30848.0 4505415
dehydrogenase/reductase member 2 isoform 1 5.10E-07 20.18 31475.6 33667109
thioredoxin 9.61E-07 20.18 11729.7 50592994
aldehyde dehydrogenase 3A1 1.98E-06 40.17 50362.9 206597439
peroxiredoxin 1 7.00E-06 20.17 22096.3 4505591
ATP synthase, H+ transporting, mitochondrial F0 complex 1.33E-05 10.15 7928.3 6005717
peroxiredoxin 6 5.07E-05 10.12 25019.2 4758638
NADH dehydrogenase 1 alpha subcomplex, 4, 9kDa 1.97E-05 10.17 9363.9 4505357
Fig. 4. NSs is associated with the mitochondria of infected cells. (A) Flag-NSs-MP-12 virus was used to infect HepG2 cells. Total cell lysates were immunoprecipitated with an
antibody against the Flag tag and subjected to LC-MS/MS analysis. (B) Crude mitochondrial preparations were obtained from Flag-NSs-MP-12 infected HepG2 cells. Total
cytoplasmic protein was maintained as controls. All lysates were analyzed by western blot for Flag (NSs), cytochrome C and actin. For the western blot analysis, a
mitochondrial pellet from approximately 107 cells was used. For the cytoplasmic component, 1/5th of protein from 107 cells was used. This difference in relative protein
utilized is indicated as 20X in the ﬁgure.
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of a MP-12 infection. However, strong colocalization with mito-
chondria was evident in multiple FLAG-positive cells (Fig. 5D)
suggesting that NSs, out of context of a viral infection, could
localize to mitochondria in HepG2 cells. Cumulatively, our mass
spectrometry studies, mitochondrial enrichment studies and con-
focal studies indicate that at least a fraction of the cytoplasmic NSs
localized in the mitochondria in infected cells.
Activation of the NFkB response and p53 response accompanies
oxidative stress in RVFV-infected liver cells
ROS has been shown to be involved in host responses to
invading pathogens by functioning as secondary signaling mes-
sengers (Waris et al., 2001; Gwinn and Vallyathan 2006; Yang
et al., 2010; Imai et al., 2008). One such host-signaling event that is
Fig. 5. NSs co-localizes with mitochondria. HepG2 cells were infected with FLAG_NSs-MP-12 and cells were ﬁxed after 24 h and stained with antibodies against the FLAG tag
and mitochondria (α-Tomm20). Images of stained cells were obtained by confocal microscopy. Representative images of HepG2 cells positive for FLAG_NSs displaying
co-localization with mitochondria are shown in A and B. Co-localization of FLAG_NSs with the mitochondria is indicated by the arrows. The co-localization was conﬁrmed by
Z-stack analysis. A total of 211 cells were visualized and counted of which 128 were positive for FLAG_NSs. Of the 128 cells, 44 cells showed co-localization of the FLAG_NSs
and the mitochondria (as inferred by the yellow staining pattern). (C) HepG2 cells were infected with FLAG_NSs-MP-12 (MOI: 3) and at 4, 6 and 24 h post infection cell
lysates were collected and protein extracted as described in the materials and methods section. Cell lysates were resolved by SDS-PAGE and western blots carried out using
anti-FLAG and anti-β-actin antibodies. (D) HepG2 cells were transfected with FLAG_NSs plasmid (1 μg) and 24 h post transfection cells were ﬁxed and stained with anti-FLAG
and anti-Tomm20 antibodies. Images of stained cells were obtained by confocal microscopy. Representative images of HepG2 cells positive for FLAG_NSs displaying
co-localization with mitochondria are shown in D. Co-localization of FLAG_NSs with the mitochondria is indicated by the arrows.
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modulated by intracellular ROS levels is the NFkB pathway. Earlier
studies performed using MP-12 infected epithelial cells have
shown the activation of the NFkB cascade at early time points
following infection (Narayanan et al., 2012). Therefore, we asked
whether the activation of NFkB components can be temporally
correlated with an increase in ROS in MP-12 infected liver cells. To
address this question, we determined whether nuclear transloca-
tion of p65 can be observed at early and late time points after
infection of HepG2 cells with wild type MP-12 or UV-MP-12.
We determined that the UV-inactivation procedure rendered the
virus replication incompetent by plaque assays (data not shown;
(Narayanan et al., 2012)). Mock infected cells were included as
controls. Additionally, we infected cells with the MP-12ΔNSs
mutant virus to evaluate the effect of NSs on the nuclear
translocation of p65. Infected cells were ﬁxed at 1 h post infection,
stained with anti-p65 antibody and visualized by confocal micro-
scopy. We observed signiﬁcant nuclear translocation of p65
following infection with MP-12 as indicated in Fig. 6A (MP-12
panel). In the case of infection by UV-MP-12, we did not observe
signiﬁcant localization of p65 in the nucleus and did not look
different from the mock infected cells. However, in the case of
MP-12ΔNSs, we observed a partial localization of p65 in the
Fig. 6. Activation and macromolecular reorganization of p65 and p53 complexes in MP-12 infected cells. (A) and (B) Nuclear translocation of p65 and p53 was determined by
confocal microscopy. MP-12, UV-MP-12, MP-12ΔNSs (MOI: 3) or mock infected HepG2s were ﬁxed at 1 and 24 h post infection and stained with anti-p65 (total) and anti-p53
(total) antibody respectively and DAPI. (C) and (D) MP-12 and mock infected HepG2 cells (MOI: 10) were lysed and total protein lysates (2 mg) were size fractionated using a
Superose 6 h 10/30 size-exclusion chromatography column using the AKTA puriﬁer system. About 50 fractions were obtained from each sample. Protein from every alternate
fraction spanning a size range between 1 mDa and 100 kDa was precipitated and analyzed by western blotting using anti-p65 (total), anti-p53 (total) and anti-β-actin
antibodies. The red squares in the p65 blot (panel C) and p53 blot (panel D) show reorganized p65 and p53 complexes that eluted in MP-12 infected samples compared to
mock infected cells. (E) and (F) Fractions 27 and 30 from UV-MP-12 and MP-12 infected lysates were utilized in a DNA binding assay using Biotin-coupled oligonucleotide
probes with binding sites to p65 and p53 respectively. The lysates were then incubated with streptavidin beads and incubated at 4 1C. The beads were then washed, proteins
eluted and analyzed by western blot for p65 and p53 binding.
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nucleus in some cases while the number of cells that were positive
for nuclear p65 was more in the case of MP-12 infected cells
(Fig. 6A). We also analyzed the phosphorylation status of p65 and
IκBα as a reﬂection of NFkB activation after MP-12 infection by
western blot analysis, which indicated an increased phosphoryla-
tion of p65 on Serine 536 and IκBα on Serine 32 (data not shown).
Cumulatively, our experiments demonstrated activation of the
NFκB cascade at early time points following RVFV infection.
A second signaling response that is activated by intracellular
ROS is DDR, due to damage to nuclear and mitochondrial DNA.
Previous studies have demonstrated that RVFV infection activates
both DDR and p53 in epithelial cells at later time points in
infection even though no signiﬁcant damage to DNA could be
detected (Baer et al., 2012; Austin et al., 2012). In order to
determine if similar responses operate in liver cells following
RVFV infection, we determined nuclear translocation of p53 at late
time points after MP-12 infection. Accordingly, HepG2 cells were
infected with either MP-12 or UV-MP-12, stained with anti-p53
antibody (total p53) and imaged by confocal microscopy. Mock
infected cells and MP-12ΔNSs infected cells were maintained as
controls. Results revealed that in the case of MP-12 infection,
nuclear p53 can be readily detected in multiple cells while in the
case of infection by the UV-inactivated virus p53 was more widely
and diffusely distributed in the cell with no apparent nuclear
enrichment (Fig. 6B). In the case of MP-12ΔNSs, we observed
occasional nuclear p53 while the number of cells positive for
nuclear p53 was signiﬁcantly higher in the case of MP-12 infected
cells. We analyzed the phosphorylation status of p53 and DDR
associated proteins Chk2 and H2AX by western blots and observed
higher levels of phosphorylation of p53 on Serine 15 and Serine
392 in MP-12 infected cells than UV-MP-12 infected cells (data not
shown). Similarly, we noted that Chk2 and H2AX were also
phosphorylated to a greater extent in MP-12 infected cells when
compared with cells infected with UV-MP-12 with no signiﬁcant
changes in total levels of H2AX and Chk2 (data not shown).
Cumulatively, these observations in liver cells mirror earlier
observations in epithelial cells in that RVFV infection activates
DDR and p53 signaling following infection. As these responses
have been observed to occur in different cell types at later time
points following infection, we suggest that RVFV infection-
triggered ROS induces the NFκB signaling cascade at early time
points and the activation of DDR and p53 responses at later time
points after exposure.
Macromolecular reorganization of p65 and p53 occurs in
RVFV-infected liver cells.
Activation of fundamental innate immune responses including
activation of p65 and p53 often involves reorganization of a macro-
molecular complex from an inhibitory conﬁguration to one that is
activating. Prior experiments that focused on multiple host kinases
that inﬂuence host innate immune response including the IKK
complex (IKK-β), GSK-3β and Cyclin T/Cdk9 demonstrated macro-
molecular reorganization of these kinase complexes in response to
viral infections (Narayanan et al., 2012a, 2012b; Kehn-Hall et al.,
2012). Typically, the reorganization of these kinases resulted in the
appearance of novel, small molecular weight species as observed by
size fractionation column chromatography approaches (Narayanan
et al., 2012a, 2012b; Kehn-Hall et al., 2012). Based on prior evidence
that viral infections induced formation of novel, functional macro-
molecular complexes, we asked whether p65 and p53 displayed any
alterations in their size fractionation proﬁles that may correlate with
their activation status. We addressed the issue by performing column
chromatography using whole cell lysates that were obtained from
HepG2 cells infected with MP-12 and UV-MP-12. We carried out
chromatography separation using a Superose 6 sizing column and
analyzed fractions that were between the 800 kDa and 100 kDa
range for distribution patterns of p65 and p53. β-actin was analyzed
as a control in both cases to monitor for presence of protein in the
analyzed fractions. We observed that in UV-MP-12 infected cells,
p65-containing complexes showed a wider distribution range from
approximately 800 kDa to about 300 kDa (Fig. 6C, lanes 2–5). In the
case of MP-12 infected cells, we noticed a decrease in the high-
molecular weight complexes (670 kDa and above; lanes 2 and 3) and
an increase in the p65-containing complexes in the 300 kDa range
(670 kDa and below; lanes 4 and 5). This reorganization of the p65
complexes was not due to changes in total p65 protein levels as
revealed by comparable p65 in the input lanes in the MP-12 and UV-
MP-12 lysates (lane 1). Similarly, we observed that in UV-MP-12
infected cells, p53 was predominantly observed between the 200
and 150 kDa range (Fig. 6D, lanes 6 and 7). In the case of MP-12
infected cells, p53 appeared to have a more stream-lined, narrow
distribution where the majority of the higher migrating form that
was visible in the UV-MP-12 infected samples (lane 6) disappeared
while p53 was concentrated in the 150–100 kDa range (lane 7, 8).
As a next step, we determined whether the low molecular
weight versions of p65 and p53 that were observed in MP-12
infected cells were functionally competent to bind appropriate
promoter sequences and how the binding of the low molecular
weight forms compared to the forms that existed in UV-MP-12
infected cells. To answer that question, we performed DNA binding
studies using fractions 27 and 30 from MP-12 and UV-MP-12
infected cell lysates using biotin labeled p65 and p53 oligonucleo-
tides (Furia et al., 2002). The experiment was carried out by
incubating fractions 27 and 30 with the appropriate biotin-
oligonucleotides. Twenty-four hours later, streptavidin beads were
added and incubated at 4 1C for a few hours. The beads were then
washed twice with high salt buffer, bound proteins eluted and
analyzed by western blot using anti-p65 and anti-p53 antibodies.
Our results demonstrated that for p65, more protein was bound to
the oligonucleotide when fraction 27 from MP-12 infected lysate
was used as compared to UV-MP-12 infected cells (Fig. 6E).
Similarly, in the case of p53, we observed an increased binding
of p53 to the corresponding oligonucleotide when the fraction was
obtained from MP-12 infected cells (Fig. 6F). Collectively, the DNA
binding studies performed with the low molecular weight com-
plexes of p65 and p53 were suggestive of the possibility that these
versions of p65 and p53 obtained from MP-12 infected cells may
be more efﬁcient in binding to DNA than those present in the UV-
MP-12 counterparts.
Cumulatively, based on size fractionation of p65 and p53-
containing complexes in MP-12 infected cells, we observe reorga-
nization of both proteins that correlate with a productive infection.
The reorganization of both proteins primarily pointed towards
appearance of low molecular weight species in the case of MP-12
infection and the low molecular weight proteins displayed efﬁ-
cient DNA binding.
RVFV infection of liver cells results in increased NFκB and p53 induced
gene expression
One of the well-documented consequences of NFκB activation
in response to upstream stimuli such as viral infection and ROS is
the increased expression of inﬂammatory cytokines that play
integral roles in downstream effects including the onset of
apoptosis and pathological outcomes. Mouse model studies have
demonstrated modulation of inﬂammatory gene expression in the
liver of RVFV infected animals, drawing connections between
inﬂammatory gene responses and hepatitis (Smith et al., 2010;
Ding et al., 2005). Therefore, we asked whether MP-12 infection
resulted in NFκB-induced alteration of cytokine expression in liver
cells. We looked at IL8 expression in infected HepG2 cells as a
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representative of inﬂammatory mediator expression. We chose IL8
as a candidate for analysis because IL8 is a potent chemoattractant
and is associated with inﬂammatory gene expression in multiple
liver-associated disease phenotypes including HCV infection
(Polyak et al., 2001a, 2001b). HepG2 cells were infected with
MP-12 and total RNA was isolated at 24 h post infection. We
performed a RT-PCR assay with IL8 primers to determine changes
in IL8 expression. GAPDH expression was analyzed alongside as a
control. We observed a strong increase in IL8 expression at 24 h
post infection (Fig. 7A). To quantitatively analyze IL8 expression in
MP-12 infected cells in comparison with either mock infected or
UV-MP-12 infected cells, we performed qRT-PCR using RNA
obtained at 24 h post infection. Levels of 18s rRNA were used to
normalize the IL8 expression numbers and the results indicated
that MP-12 infection resulted in a robust increase in IL8 expression
(Fig. 7B). To compare with the increase in gene expression, we also
determined secreted IL8 protein in the supernatants of infected
cells. As the viral protein NSs is known to suppress the innate
immune inﬂammatory response, we performed ELISAs to compare
IL8 levels in the supernatants of MP-12 infected HepG2 cells with
those infected with the NSs and NSm mutant viruses. As expected,
we observed an increase in IL8 in the supernatants of MP-12
infected cells when compared to the mock-infected control. In the
case of the NSs mutant, there was more IL8 in the medium when
compared to MP-12 infected cells while the NSm mutant did not
inﬂuence IL8 secretion signiﬁcantly (Fig. 7C, left panel).
In order to analyze differences in the amounts of IL8 in the
media in a more sensitive manner, we utilized hydrogel nanopar-
ticles that have been demonstrated to successfully capture and
enrich low molecular weight analytes. The captured analytes can be
subsequently detected by conventional methods such as ELISA
(Tamburro et al., 2011; Longo et al., 2009; Fredolini et al., 2008).
Analyte capture is mediated by speciﬁc chemical baits incorporated
into the nanoparticles and the capture efﬁciency is enhanced by
the porosity of the particle that permits size sieving. Speciﬁcally,
the nanoparticles have been demonstrated to capture and pre-
serve IL8 from enzymatic degradation (Tamburro et al., 2011).
Supernatants from MP-12 infected cell cultures and NSs and NSm
mutant virus infected cultures were incubated with hydrogel
nanoparticles (with a cibacron blue bait and a VSA shell) for 1 h
after which the particles were pelleted and bound IL8 eluted. The
eluted protein was then analyzed by ELISA to obtain more
sensitive and quantitative differences in IL8 secretion. Accord-
ingly, we observed 43-fold increase in IL8 protein secreted in
the culture supernatant of MP-12 infected liver cells over control.
More elevated levels of IL8 could be detected in the supernatants
of cells infected with NSs mutant virus while the NSm mutant
virus actually resulted in lower levels of IL8 in the media when
compared to MP-12 infection (Fig. 7C, right panel). Therefore, our
data suggests that MP-12 infection of liver cells results in both
increased IL8 gene expression and protein expression levels.
Treatment with antioxidants reversed the observed phenotypic
phenomena associated with MP-12 infection
We reasoned that if the observed increase in superoxide levels
in MP-12 infected cells contributed to the down stream effects
including activation of p65 and p53, activated expression of
inﬂammatory mediators, and activated expression of apoptosis
associated genes and increased apoptosis, controlling increase in
superoxide at early time points of infection by antioxidants should
reverse those phenotypic endpoints. We ﬁrst checked if treatment
of HepG2 cells with a well-documented antioxidant, curcumin,
decreased superoxide levels in infected cells. HepG2 cells were
pretreated with curcumin (1 mM) for 1 h and then infected with
MP-12. Cells were stained with MitoSox at 3 h post infection and
analyzed by confocal microscopy, which showed a marked
decrease in intracellular superoxide levels (Fig. 8A).
As a next step, we determined if controlling early induction of
superoxide by curcumin inhibited nuclear translocation of p65 at
early time points and p53 at later time frames following infection.
HepG2 cells were pretreated with curcumin (1 mM) and infected with
MP-12 virus. Infected, untreated cells and mock infected cells were
maintained as controls. Cells were ﬁxed at 1 h post infection and
stained for p65 localization (Fig. 8B). The results demonstrated that
pretreatment of HepG2 cells with curcumin decreased nuclear
localization of p65 in infected cells. We performed a similar experi-
ment to determine the consequence of pretreatment with antiox-
idants on nuclear migration of p53 at later time frames in MP-12
infected cells. Results followed a similar pattern to p65, indicating a
decreased nuclear migration of p53 (Fig. 8B).
We then determined whether pretreatment of cells with the
antioxidant attenuated expression of inﬂammatory mediators. We
isolated total RNA from cells infected with the MP-12 virus or the
UV-MP-12 virus at 24 h post infection, and RNA was also isolated
from untreated cells and curcumin treated cells. We performed
qRT-PCR for multiple cytokines including IL2, IL4, IL6 and IL8 and
noticed that pretreatment with the antioxidant robustly down
regulated inﬂammatory gene expression. Curcumin has a long
standing record of being an anti-inﬂammatory molecule (Zhang
Fig. 7. NFκB mediated cytokine expression and p53 mediated proapoptotic gene
expression are increased in MP-12 infected cells. (A) MP-12 (I) and mock infected
(M) cells were lysed at 24 h post infection and total RNA was isolated. The
expression of IL8 was determined by RT-PCR with IL8 speciﬁc primers. GAPDH
expression was determined using GAPDH-primers as a control. (B) MP-12, UV-MP-
12 infected cells and mock infected cells were lysed at 24 h post infection and qRT-
PCR was performed with primers to IL8. 18sRNA expression levels were used to
normalize IL8 levels. (C) Supernatants from MP-12, MP-12ΔNSs and MP-12ΔNSm
infected cells were obtained at 24 h post infection and analyzed by ELISA for IL8
protein. In the left panel, all supernatants (100 ml per sample) were analyzed
without any kind of enrichment. In the right panel, 8 ml of supernatant from each
infection was incubated with hydrogel nanoparticles (cibacron blue bait and VSA
shell) for 1 h at room temperature, the particles spun down by high speed
centrifugation (10,000 rpm for 15 min) and contents eluted in water (100 ml). ELISA
was then performed using the entire eluted volume for presence of IL8 protein.
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Fig. 8. Antioxidants reverse apoptotic and cytokine gene expression, decrease apoptosis and viral multiplication in infected cells. (A) HepG2 cells were either infected with
MP-12 (MOI: 3) or pretreated with curcumin (1 μM) and then infected with MP-12 (MOI: 3). Cells were stained with Mitosox and DAPI and imaged by confocal microscopy.
(B) and (C) HepG2 cells were either mock infected, MP-12 infected or pretreated with curcumin (1 μM) and then infected with MP-12 (MOI: 3). Cells were ﬁxed at 1(B) and 24
(C) hours post infections and stained for p65 and p53 respectively and DAPI. (D) HepG2 cells were mock infected, MP-12, UV-MP-12 infected or pretreated with curcumin
(1 μM) and then infected with MP-12 (MOI: 3). Levels of IL2, IL4, IL6 and IL8 were quantiﬁed by qRT-PCR and are represented graphically. (E) HepG2 cells were pretreated
with curcumin and quercetin (0.1 and 1 mM) for 2 h, infected with MP-12 virus or mock infected and post treated with the antioxidants for up to 24 h. Cells treated with
DMSO alone were maintained as controls. Total RNA was obtained and analyzed by qRT-PCR with primers against Bcl2, Bcl-XL and NOXA. (F) HepG2 cells were either mock,
MP-12 infected or pretreated with curcumin and then infected with MP-12. Total protein was resolved by SDS-PAGE. Western blot was performed with antibody against
caspase 3 (recognizes both cleaved [Cl] and full length [FL] forms. Fold change in intensities of the 11 kDa cleavage product is indicated at the bottom. Β-Actin served as a
loading control.
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et al., 2011; Aftab and Vieira, 2010; Jackson et al., 2006) and our
current result reproduced that trend (Fig. 8D). We also looked at
the expression of genes associated with the onset of apoptosis that
were regulated by p53 and p65 in the presence of curcumin. Total
RNA from MP-12 and UV-MP-12 infected cells was obtained and
analyzed by qRT-PCR with primers against pro- and anti-apoptotic
genes including Bcl2, Bcl-XL, and Noxa. The most prominent
change in gene expression was observed for Noxa, which agrees
with our earlier published data although those studies were done
in epithelial cells (37). This increase in Noxa expression can be
observed in the sample marked DMSO which actually refers to
MP-12 infected cells which were treated with the DMSO control
(Fig. 8E). In the case of infected cells, which were treated with
increasing concentrations of curcumin or Quercetin, another anti-
oxidant (Zhang et al., 2011; Aftab and Vieira 2010; Jackson et al.,
2006), the Noxa expression levels decreased (Fig. 8E). In the case
of quercetin, we noticed that in addition to down regulating Noxa,
there was an increase in the expression of Bcl-2 in treated cells,
thus alluding to the onset of an anti-apoptotic phenotype.
Finally, we asked whether these observed changes in p65 and
p53 localization and alteration of inﬂammatory and apoptotic gene
expression by antioxidant treatment reﬂected as reduced apopto-
sis of infected cells. To answer this question, we performed
western blots to determine caspase 3 cleavage as a marker of
apoptosis. MP-12 infected, untreated cells were compared with
MP-12 infected, curcumin treated cells and mock infected cells.
The results suggested that pronounced cleavage of caspase 3 could
be observed in the MP-12 infected cells but that it was reduced in
the presence of the antioxidant (Fig. 8F).
Cumulatively, our data suggested that pretreatment of MP-12
infected HepG2 cells with an antioxidant lowered the levels of reactive
superoxide during the early stages of the infectious process, which
reﬂected as reduced activation of p65 and p53, reduced inﬂammatory
and apoptotic gene expression, and, ﬁnally, reduced apoptosis.
MP-12 infection of primary hepatocytes resulted in induction
of reactive superoxide species
We wanted to determine if the changes relevant to NSs-depen-
dent superoxide increase in MP-12 infected HepG2 cells recapitulated
in a primary hepatocyte cell system. To address this question,
primary hepatocytes were infected with MP-12, UV-MP-12 and
MP-12ΔNSs viruses. Mock infected cells were maintained as
controls. Cells were plated in eight chambered collagen coated
glass slides, infected with the virus strains (MOI:3) and stained
with MitoSox at 3 h and 6 h post infection. Microscopic observa-
tion indicated that in the case of all viral exposures a strong
nuclear signal was observed at the early time point and that at the
6 h time point the mock infected cells also showed intense nuclear
staining. This led us to conclude that the nuclear staining phe-
nomenon may be a nonspeciﬁc event in the case of primary
hepatocytes (Fig. 9A and B). However, at both the 3 and 6 h time
points, we noticed intense cytoplasmic staining in the case of MP-
12 infected cells while this phenotype could not be observed in the
case of UV-MP-12 infected and MP-12ΔNSs infected cells. Cumu-
latively, the data suggested that a NSs mediated early increase of
superoxide species in MP-12 infection can be observed in primary
hepatocytes.
Discussion
RVFV infections have often been associated with pronounced
liver damage with in vivo evidence indicating apoptosis of liver
cells (Smith et al., 2010, 2012; Ding et al., 2005). The exact
mechanisms that contribute to the liver damage in the face of
RVFV infection is however unclear. Our previous publications that
have investigated host response to RVFV infection have indicated
that multiple host phospho-signaling pathways exert a strong
inﬂuence on the apoptotic versus antiapoptotic environment of
the cell (Popova et al., 2010). We had demonstrated that both
NFκB and p53-based signaling responses were activated during
infection in the case of lung epithelial cells and these signaling
responses were necessary for viral replication (Baer et al., 2012;
Narayanan et al., 2012; Austin et al., 2012). An upstream event that
is known to inﬂuence both NFκB and p53 responses is oxidative
stress. We had shown that RVFV infection increased the levels of
expression of superoxide dismutase 1 (SOD1), and activated p38
MAPK-based stress responses (Narayanan et al., 2011). Therefore,
prior data suggested that increase in ROS may be an important
Fig. 9. ROS activation in MP-12 infected human primary hepatocytes. Human primary hepatocytes were either mock, MP-12, UV-MP-12 or MP-12ΔNSs infected (MOI: 3).
Three (A) and 6 (B) hours post infection hepatocytes were stained with MitoSox and DAPI and imaged by confocal microscopy.
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component in pathology associated with RVFV infection, thus
prompting the question of whether increased ROS may play a role
in the observed apoptosis of liver cells. To test this possibility, we
directly determined ROS levels in MP-12 infected HepG2 cells at
early time points after infection. Our data indicated that there
was an increase in MitoSox ﬂuorescence (reﬂective of intracel-
lular ROS) in infected cells over uninfected cells at 3 h post
infection (Fig. 1). In the absence of the viral protein NSs, we
noticed decreased MitoSox staining at early time points after
infection (Fig. 2A, B) while this effect disappeared at later
time points (Fig. 2C, D). This suggested that the involvement
of NSs in oxidative stress responses may be more pronounced
at early time points while at later time points additional viral
and host components may be involved in the increase in
intracellular ROS.
Our data demonstrates that NSs may be associated with
components of the mitochondria in infected cells (Figs. 3 and 4).
This observation could explain the decreased ROS detected at early
time points with the NSs mutant virus. Many studies have demon-
strated association of viral proteins with the mitochondria and the
resultant effect on host response to an infection. A recent report by
Terasaki et al. has demonstrated that the C-terminal region of the
antiapoptotic NSm protein of RVFV may target NSm to the mito-
chondria of infected cells and this may be related to the antiapop-
totic phenotype observed with the NSm mutant virus (Terasaki
et al., 2013). HCV proteins have also been demonstrated to target
the mitochondria and cause alteration of mitochondrial function
that contributes to potent imbalances in the redox potential
resulting in oxidative stress induced inﬂammation (Piccoli et al.,
2007). NSs, by its association with the F0 or F1 complex of the
mitochondria, could inﬂuence early increase in intracellular ROS
levels by disrupting the electron transport chain. The disruption can
occur either because of a functional compromise of key subunits
such as NADPH oxidase, or due to ion imbalances such as calcium
inﬂux into the mitochondria or both. Both of these events have
been known to occur due to virus protein-mediated mitochondrial
disruption that results in increased intracellular ROS due to disrup-
tion of the mitochondrial electron transport machinery (Piccoli
et al., 2007; Korenaga et al., 2005).
A delicate balance of the intracellular ROS level is an important
requirement for the maintenance of cell homeostasis. However,
the adverse effect of unregulated intracellular ROS is that these
reactive species would nonspeciﬁcally oxidize many essential
cellular macromolecules resulting in acute damage to the cell
and disruption of essential cellular functions. Persistent imbalance
in ROS in spite of cellular antioxidant mechanisms is indicative of
breakdown of regulatory mechanisms that often culminate in
apoptosis. ROS, therefore, also acts as a secondary messenger to
activate many host signaling responses, including NFkB and p53
(Gong et al., 2001; Waris et al., 2001; Gwinn and Vallyathan,
2006). Consequently, we asked whether p65 (a key effector
protein of the NFkB signaling cascade) and p53 were activated in
infected liver cells. Our experiments demonstrated that both p65
and p53 are localized to the nucleus in liver cells infected with
RVFV (Fig. 6A, B).
One of the hallmarks of NFκB activation and prerequisite
for p65 translocation to the nucleus is a reorganization of the
p65-containing complex in the cytoplasm. p65 is retained in the
cytoplasm as a complex with the inhibitory IκBα protein. A central
kinase of the NFκB cascade is the IκB kinase complex (IKK) that
phosphorylates IκBα, which is then proteomically degraded. This
releases p65, which then associates with p50 and translocates to
the nucleus where it binds κB elements on select sets of genes and
activates transcription. Our earlier studies have demonstrated that
viral infection led to profound alterations of multiple host reg-
ulatory components including kinases that inﬂuenced viral
multiplication and pathological outcomes in the host (Narayanan
et al., 2012a, 2012b; Kehn-Hall et al., 2012; Ramakrishnan et al.,
2012). We reasoned that p65 would be reorganized in these cells
as IκBα would be phosphorylated and degraded. To determine if
this occurred in RVFV infected liver cells, we fractionated cell
lysates using size fractionation chromatographic methods and
analyzed p65 distribution based on size. Our data revealed that
p65 which showed a wide distribution range from 800 kDa to
500 kDa in mock infected cells was restricted to a much narrower
range closer to 670 to 500 kDa in RVFV infected cells (Fig. 6C).
When we tested for p53 distribution in a similar manner, we made
comparable observations in that p53 in infected cells was
restricted to a narrower size range than in mock infected cells,
although the observed shift was relatively modest when compared
to p65 (Fig. 6D). This reorganization of p65 and p53 in infected
cells to smaller-sized complexes may be attributed to removal of
inhibitory proteins that would otherwise retain these transcription
factors in the cytoplasm. Functionally, it is interesting to speculate
that the lower molecular weight complexes may lack inhibitory
components for promoter binding and therefore may be able to
bind to promoters more easily and facilitate transcription. Our
DNA binding studies using the low molecular weight versions of
p65 and p53 supported this idea and we observed increased
binding of both proteins with corresponding DNA sequences
(Fig. 6E, F). It may be possible that the higher DNA binding
property of these low molecular weight proteins is due to addi-
tional modiﬁcations such as phosphorylation or acetylation which
may serve as intracellular switches that inﬂuence transcriptional
regulation (Furia et al., 2002; Chen et al., 2001, 2002; Kim et al.,
2012; Jain et al., 2012).
Induction of cytokine responses as a consequence of infection
leads to inﬂammation in affected tissues. When we analyzed gene
and protein expression proﬁles of inﬂammatory cytokines in liver
cells following RVFV infection, we observed that IL8 expression
was induced at both the gene and protein expression levels
(Fig. 7). The connection between liver injury, apoptosis, IL8 and
NFκB activation has been well established in the case of HCV
infections where infection induced NFκB activation led to
increased IL8 expression and apoptosis, as reﬂected by caspase
3 cleavage (Balasubramanian et al., 2005). Similarly, IL8 induction
in liver cells following CCHF infection culminating in apoptosis has
also been documented (Smith et al., 2012). Increased cytokines are
connected with induction of apoptosis phenotypes in the liver and
are often considered to be biomarkers of liver cytotoxicity (Komita
et al., 2006; Sharma et al., 2005; Duran et al., 2004; Chalaris et al.,
2007; Lacour et al., 2005). These cytokines induce intracellular
signaling mechanisms such as STAT signaling that leads to apop-
tosis and hepatitis (Duran et al., 2004). We also observed a potent
increase in the expression of p53-modulated Noxa gene expres-
sion at later time points of infection (data not shown). The
increase in expression of Noxa was previously documented in
epithelial cells following RVFV infection (Baer et al., 2012).
Increase in expression of these inﬂammatory mediators and p53-
responsive genes will contribute directly to the onset of apoptosis
(Bantel and Schulze-Osthoff 2003; Tonino et al., 2011; Yee et al.,
2011). Our data on ROS activation indicated that NSs mediated
activation of ROS was an early event during the infectious process.
However, ROS activation at a later time point proceeded regardless
of NSs suggesting that additional events mediated the onset of
oxidative stress at later time points.
In order to establish a link between the increase in ROS and
increase in apoptosis inducing gene expression proﬁles, we treated
HepG2 cells with increasing concentrations of free radical scaven-
gers such as curcumin. We observed that pretreatment of infected
cells with antioxidants reversed many of the deleterious outcomes
of MP-12 infection including reduction of free superoxide species,
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reduced activation of p65 and p53, reduced induction of inﬂam-
matory and apoptotic gene expression, and, ﬁnally, reduced
incidence of apoptosis (Fig. 8). It is possible that decrease in
apoptotic gene expression and proinﬂammatory cytokine produc-
tion may be a result of decreased viral multiplication in the
presence of antioxidants, as our previous manuscript had demon-
strated that curcumin inhibits RVFV multiplication (Narayanan
et al., 2012).
In conclusion, our data supports the idea that RVFV infection
leads to increased ROS in infected liver cells that activates NFκB
responses early in infection and p53 responses later in infection.
These transcription factors in turn augment cytokine responses
and pro-apoptotic gene expression in the infected cells that
culminate in apoptosis mediated cell death. These sets of data
provide compelling evidence for the use of antioxidants to achieve
better hepatoprotection and possibly decrease pathogen multi-
plication in the case of RVFV infections, as in the case of HCV
infection.
Materials and methods
Viruses and cell lines
The attenuated RVFV strain, MP-12 used in this study was
obtained by 12 serial passages of the virulent ZH548 virus in the
presence of 5-ﬂuorouracil that resulted in a total of 25 mutations
spanning the L, M and S segments of the viral genome (Vialat et al.,
1997; Caplen et al., 1985). Other strains included are the MP-
12ΔNSm strain and the MP-12ΔNSs. MP-12ΔNSm (arMP-12-
del21/384) has a large deletion in the pre-Gn region of the
M segment and as a result does not express NSm, 78 kDa, 75 kDa,
or 73 kDa proteins encoded by this region (Won et al., 2007). MP-
12ΔNSs (rMP-12-NSdel) completely lacks the NSs ORF (Ikegami
et al., 2006). Flag-tagged NSs virus has a C-terminal Flag-tagged NSs
inserted in place of NSs in the MP-12 backbone (Ikegami et al.,
2009). MP-12 strain was inactivated by exposing virus to ultraviolet
radiation and termed UV-MP-12 (Narayanan et al., 2012). Human
liver ﬁbroblast cells (HepG2 cells) were maintained in 50% DMEM,
50% Ham's F-12, 10% Fetal Bovine Serum (FBS), 1% Penicillin/
Streptomycin and 1% L-Glutamine at 37 1C, 5% CO2. Vero cells were
maintained in DMEM containing 10% FBS, 1% Penicillin/Streptomy-
cin and 1% L-Glutamine at 37 1C, 5% CO2.
Primary hepatocyte coculture
Hepatic stellate cell line (CFSC-8B), used as a feeder cell layer, was
plated at 106 cells per 25 cm2 culture ﬂasks in minimal essential
medium (MEM, Invitrogen) supplemented with 10% fetal bovine
serum (FBS), antibiotics (penicillin/streptomycin 100 IU/mL; Quality
Biological), and 1% nonessential amino acids (Cellgro). After 2 h
the MEM was replaced and 5106 freshly isolated human hepato-
cytes suspension (Cambrex, Walkersville, MD) was seeded over the
feeder cell line in a hepatocyte-deﬁned medium (HDM, human
hepatocyte growth medium). Following 3 h incubation, and monitor-
ing cell attachment, the hepatocyte cocultures were grown in
HDM comprised of: Dulbecco's modiﬁed Eagle medium (DMEM)
with D-glucose 0.45%, L-glutamine 5 mM, without sodium pyruvate,
and supplemented with albumin 0.2%, glucose 0.2%, galactose 0.2%,
ornithine 0.01%, proline 0.003%, nicotinamide 0.061%, insulin-
transferrin-sodium selinite (ITS, Sigma) 0.1%, ZnCl2 0.544 ug/mL,
ZnSO4 0.75 ug/mL, CuSO4 0.2 ug/mL, MnSO4 0.025 ug/L, transforming
growth factor-alpha (TGF-α) 20 ng/mL, and penicillin 100 units/mL,
streptomycin 100 ug/mL, and dexamethasone 107 M. The HDM
culture medium was replaced every 48 h. Primary hepatocyte
cultures form spherical masses after 30 days in coculture. The
hepatocyte cultures containing spherical masses were harvested
with 0.05% trypsin in HDM (supplemented with 1% FBS) and
reseeded at 5104 cells/six-well plates and propagated in HDM
(the plating efﬁciency was 90–95%). The monolayer cultures in six-
well plates (which were used for most experiments) were reseeded
at 10-day intervals. The ‘‘maintenance cultures’’ when allowed to
grow for more than 4 weeks in HDM reform the spherical masses
(fromwhich monolayer culture of primary hepatocyte was derived as
outlined). The ‘‘passage’’ numbers of post-attachment primary hepa-
tocytes (PPH) cultures are recorded and refer to reseeding from the
reformed primary hepatocyte containing spheroids in maintenance
cultures. (Banaudha et al., 2010, 2011). For the MitoSOX staining
experiment, a frozen stock of primary hepatocytes was thawed and
seeded in collagen coated eight well chamber slides (BD Biocoat
Collagen Type I cellware), at a density of 100,000 cells per well. Vero
cells were also seeded on the same slides (50,000 cells per well) to
serve as positive control for infection. Following an overnight
incubation to allow attachment, one extra well of primary hepato-
cytes was gently washed once with media and subsequently a viable
cell count was obtained for the well as described in the section below
(Cell Viability Assays). Subsequently, the following treatment condi-
tions were set up: (A) uninfected (control); (B) infection with
recombinant MP-12 (rMP-12) at MOI 3; (C) infection with UV-
inactivated recombinant MP-12 (rMP-12) at MOI 3; (D) infection
with ΔNSs mutant derivative at MOI 3.The virus was removed after
1 h and replaced with media. MitoSOX staining to detect reactive
oxygen species was performed as described below in the methods
section (Reactive oxygen species detection).
Cell viability assays
Primary hepatocytes were seeded in collagen coated eight well
chamber slides (BD Biocoat Collagen Type I cellware), at 100,000
cells per well, and cell viability was measured after 24 h, just prior
to the start of infections. For viability measurement, the cells were
trypsinized and washed with media. A volume of 10 μl of cell
suspension was then mixed with 10 Trypan blue staining solution
and 10 μl of this mix was used to count the number of live cells by
a hemocytometer
Viral infections and protein extract preparation
HepG2 cells were seeded at a density of 1106 cells per well in
6-well plates. The cells were infected with MP-12 for 1 h to allow
for viral adsorption at 37 1C. The viral inoculum was removed and
replaced with media. The cells were incubated for appropriate
time frames at 37 1C, 5% CO2. To prepare cell lysates, the media was
removed and the cells were washed twice with PBS. Following the
PBS wash, the cells were lysed with lysis buffer that consisted of a
1:1 mixture of T-PER reagent (Pierce, IL), 2X Tris-glycine SDS
sample buffer (Novex, Invitrogen), 2.5% β-mercaptoethanol, and
protease and phosphatase inhibitor cocktail (1X Halt cocktail,
Pierce). The cell lysates were collected and boiled for 10 min and
stored at 80 1C until analyzed.
Reactive oxygen species detection
To detect ROS in infected cells, 1105 HepG2 cells were seeded
per well in an eight-chamber slide. The slides were incubated at
37 1C, 5% CO2 overnight and infected with MP-12, MP-12ΔNSs or
MP-12ΔNSm as described earlier. At appropriate time points
following infection, MitoSox reagent (Invitrogen, Cat#M36008)
was added according to manufacturer’s instructions (Narayanan
et al., 2011). Cells were imaged using Nikon Eclipse TE2000-U.
EZ-C1 software was used to perform statistical analysis to quantify
ﬂuorescence intensities.
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Crude mitochondrial preparation
Cells were trypsinized and washed with cold PBS. The washed
cells were resuspended in ﬁve times the pellet volume of cold
isolation buffer that consisted of Mannitol (0.3 M), BSA (0.1%), EDTA
(0.2 mM EDTA), HEPES (10 mM) and pH adjusted to 7.4 with KOH.
The cell pellet was sheared by passing through a 22-gauge needle
multiple times and the resultant lysate centrifuged at 1000 g for
10 min at 4 1C. The pellet was discarded and the supernatant spun at
14,000 g for 15 min at 4 1C. The supernatant was saved as the
cytoplasmic fraction and the pellet saved as the mitochondrial
fraction. The pellet was washed twice with cold isolation buffer,
diluted in SDS containing buffer and electrophoresed.
Immunoprecipitation
HepG2 cells were infected with Flag-NSs-MP-12 virus (MOI: 5)
and maintained at 37 1C for 24 h. Cells were pelleted and lysed in a
buffer containing Tris–HCl (pH 7.5), NaCl (120 mM), EDTA (5 mM),
NP-40 (0.5%), NaF (50 mM), Na3VO4 (0.2 mM), DTT (1 mM) and one
tablet complete protease inhibitor cocktail per 50 ml. Lysis was
performed under ice-cold conditions where the cell pellets were
incubated with buffer on ice for 30 min and spun at 4 1C for 5 min at
14,000 rpm. Supernatant was transferred to a new tube and protein
was quantitated with Bradford protein assay (BioRad, Hercules, CA,
USA). Whole cell extract (2 mg) was incubated overnight, rotating,
at 4 1C with α-IgG, or α-Flag antibody. The next day, 30 ml of a 30%
slurry of Protein AþG beads (Calbiochem, Rockland, MA) was added
to the IPs and incubated for 2 h, rotating, at 4 1C. The IPs were spun
brieﬂy and beads were washed 1 with TNE150þ0.1% NP-40,
followed by a 1 wash with TNE50þ0.1% NP-40. The beads were
directly lysed with Urea (8M) after which the supernatant was
processed for mass spectrometry.
Mass spectrometry
LC-MS/MS analysis was carried out as previously described
(Narayanan et al., 2012). Brieﬂy, samples were ﬁrst lysed in 8M urea,
after which, they were reduced using DTT and acetylated using
iodoacetamide. The reduced and alkylated proteins were trypsin
digested (Trypsin, Promega) for 4 h at 37 1C. The digested peptides
were eluted using ZipTip puriﬁcation (Millipore) and identiﬁcation of
the peptides was performed by LTQ-tandem MS/MS equipped with a
reverse-phase liquid chromatography nanospray (ThermoFisher).
After sample injection, the column was washed for 5 min at
200 nl/min with 0.1% formic acid; peptides were eluted using a 50-
min linear gradient from 0 to 40% acetonitrile and an additional step
of 80% acetonitrile (all in 0.1% formic acid) for 5 min. The LTQ-MS was
operated in a data-dependent mode in which each full MS scan was
followed by ﬁve MS-MS scans where the ﬁve most abundant
molecular ions were dynamically selected and fragmented by
collision-induced dissociation using normalized collision energy of
35%. Tandemmass spectra were matched against the National Center
for Biotechnology Information mouse database by Sequest Bioworks
software (ThermoFisher) using full tryptic cleavage constraints and
static cysteine alkylation by iodoacetamide.
Immunoﬂuorescence
HepG2 cells were seeded at 1106 cells per well on coverslips
in a 6-well plate. The cells were infected with MP-12 as described
earlier. At appropriate time points, cells were ﬁxed with 4%
paraformaldehyde for 20 min. Cells were permeabilized with
0.5% Triton X-100 in PBS for 15 min. Slides were washed with
PBS and blocked at room temperature for 10 min with 1% FBS. The
slides were incubated with α-FLAG, α-Tomm20 (Abcam, Cat#
ab78547), p65 (Cell Signaling, Cat# 4764S), p53 (Cell Signaling,
Cat# 9282S) primary antibody for 1 h in the dark at 37 1C. The
slides were washed three times with PBS and incubated with
secondary antibodies for 1 h in the dark at 37 1C. Slides were
washed three times with PBS and incubated with DAPI for 10 min
in the dark at room temperature. Slides were washed once with
PBS and mounted with Fluoromount G (SouthernBiotech,
Cat#0100-01) and stored in the dark, at 4 1C overnight. The cells
were imaged using Nikon Eclipse TE2000-U.
Column fractionation
The details of the column fractionation approach have been
extensively described previously (Narayanan et al., 2012a, 2012b;
Kehn-Hall et al., 2012). Brieﬂy, HepG2 cells were seeded in T-150
ﬂasks and incubated until conﬂuent. A ﬂask was infected with
MP-12 virus (MOI: 10). Twenty-four hours post infection, the cells
were harvested and pelleted by centrifugation (1200 rpm for
10 min at 4 1C). The cell pellets were lysed (50 mM Tris– HCl (pH
7.5), 120 mM NaCl, 5 mM ethylenediaminetetraacetic acid, 0.5%
NP-40, 50 mM NaF, 0.2 mM Na3VO4, 1 mM DTT, and one complete
protease cocktail tablet/50 mL) and 2 mg of protein was used for
chromatography using a Superose 6 h 10/30 size-exclusion chro-
matography column and an AKTA puriﬁer system (GE Healthcare,
Piscataway, NJ, USA). A quarter inch gap was introduced to the top
of the Superose 6 column to better separate small molecular
weight complexes from fractions eluting off the far right side of
the chromatogram. After sample injection (using 1 ml loop),
running buffer was set at a ﬂow rate of 0.3 ml/min and 0.5 ml
fractions of the ﬂow-through were collected at 4 1C for a total of
approximately 50 fractions. The columns employed in this study
were used for multiple runs prior to fractionation of the actual
virus-infected or uninfected control extracts. This is a critical step
to ensure reproducibility of fractionation proﬁles. Approximately
50 fractions were collected and fractions spanning a range of
1 mDa to 100 kDa were acetone precipitated using four volumes of
ice-cold 100% acetone. Lysates were centrifuged at 4 1C f or 10 min
at 12,000 rpm, supernatants were removed, and the pellets were
allowed to dry for a few minutes at room temperature. The pellets
were resuspended in Laemmli buffer and analyzed by immuno-
blotting for p65, p53 and β-actin.
Western blot analysis
Whole cell or fractionated lysates were separated on a 4–20%
Tris-Glycine Gel and transferred to a polyvinyl diﬂuoride (PVDF)
membrane using the iBlot gel transfer system (Invitrogen). The
membranes were blocked in 1% dry milk in PBS-T at room
temperature. Primary antibodies to RVFV (ProSci, Cat# 4519), total
p65 (Santa Cruz Biotechnology, Inc. Cat# sc7151), phospho-p65
(ser536) (Santacruz biotechnology, Inc., Cat# 33020), total p53
(Cell Signaling, Cat# 9282S), phospho-p53 (Ser15) (Cell Signaling,
Cat# 9284S), Cytochrome C (Abcam, Cat# ab13575) and HRP
conjugated actin (Abcam, Cat# ab49900) were used according to
manufacturer’s instructions and the blots were incubated over-
night at 4 1C. The blots were washed three times with PBS-T and
incubated with secondary HRP coupled goat anti-rabbit antibody
(Cell Signaling, Cat# 7074). The blots were visualized by chemilu-
minescence using SuperSignal West Femto Maximum Sensitivity
Substrate Kit (ThermoScientiﬁc) and a BIO-RAD Molecular Imager
ChemiDoc XRS system (BIO-RAD). Signal intensities were calcu-
lated using Quantity One 4.6.5 software (BIO-RAD).
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Quantitative RT-PCR
To determine expression of IL2, IL4, IL6 and IL8 following RVFV
infection, 1106 cells were seeded in a 6-well plate. Infections
were carried out as described earlier and total RNA was isolated
using the Qiagen RNeasy mini kit (Qiagen, Cat#74104) as per
manufacturer's instructions. Isolated RNA was converted to cDNA
and directly utilized to determine gene expression proﬁles of using
primers to IL2, IL4, IL6 and IL8. The primers used for the PCRs are
as follows:
IL2 fwd: 5′ AAC TCC TGT CTT GCA TTG CAC 3′
IL2 rev: 5′ GCT CCA GTT GTA GCT GTG TTT 3′
IL4 fwd: 5′ CCA ACT GCT TCC CCC TCT G 3′
IL4 rev: 5′ TCT GTT ACG GTC AAC TCG GTG 3′
IL6 fwd: 5′ ACT CAC CTC TTC AGA ACG AAT TG 3′
IL6 rev: 5′ GTC GAG GAT GTA CCG AAT TTG T 3′.
Details of the IL8 primers have been published (Mahieux et al.,
2001). All reactions were carried out in triplicate, and gene
expression levels were calculated relative to GAPDH levels or 18s
RNA levels as endogenous controls. Relative expression was
calculated as 2 (Ct gene under investigationCt GAPDH).
Rt-PCR
In order to determine IL8 expression, 1106 HepG2 cells were
seeded in a 6-well plate and infected with MP-12 as described
earlier. Total RNA was isolated using the Qiagen RNeasy mini kit
and cDNA was generated using Superscript Reverse Transcriptase
cDNA kit (Invitrogen, Cat# 11917-010). The cDNA was utilized to
perform RT-PCR reactions (35 cycles). The PCR products were
resolved in 2% agarose gels and stained with ethidium bromide.
The stained gels were visualized using the Bio Rad Molecular
Imager ChemiDoc XRS system (Bio Rad) and band intensities were
calculated using Quantity One 4.6.5 software (Bio Rad).
ELISA and hydrogel nanoparticles
Evaluation of secreted IL8 was performed using standard ELISA
methods using the human IL8 ELISA kit from BD biosciences (BD
OptEIA, Cat#550999) following manufacturer's instructions. The
hydrogel nanoparticles used to concentrate IL8 from culture
supernatants have been described in detail previously (Polyak
et al., 2001a, 2001b; Tamburro et al., 2011). When hydrogel
nanoparticles were utilized for sample concentration, 8 ml of
culture supernatant was mixed with 1 ml of hydrogel nanoparti-
cles (Cibacron blue bait and VSA shell) and incubated for 1 h at
room temperature. The particles were then centrifuged at high
speed (10,000 rpm for 15 min) and resuspended in 1 ml of water.
Particle bound IL8 was eluted by washing particles with NaSCN
(0.25M) and eluting using a 70% acetonitrile, 10% ammonium
hydroxide buffer (Polyak et al., 2001b). Samples were dried using
a Speed Vac (ThermoFisher) and resuspended in 100 ul of water.
The samples were then analyzed by ELISA.
Inhibitor studies
HepG2 cells were seeded in 96-well plates at 5104 cells/well
24 h prior to infection. For confocal experiments, cells were seeded
in 8-chambered slides. Cells were pretreated with inhibitors
Curcumin (Santacruz biotechnology, Inc., Cat# sc-200509) and
Quercetin (Sigma, Cat# Q4951) for 2 h. The conditioned media
(media containing inhibitor) was removed and viral infections
were conducted for 1 h. The viral inoculum was removed and
replaced with conditioned media. The cells were incubated for a
further 24 h at 37 1C, 5% CO2 and subsequently lysed for analysis.
Plaque assay
Quantiﬁcation of infectious particles from viral supernatants
was determined by plaque assay. Vero cells were seeded at a
density of 5105 cells per well in a 6-well plate. The next day,
dilutions of viral supernatants were made in DMEM, and applied
to wells in duplicate. Plates were incubated at 37 1C, 5% CO2 for 1 h
with occasional rocking. A 3 ml overlay comprising 2X E-MEM and
0.6% agarose (1:1) was added to each of the wells. Once solidiﬁed,
the plates were incubated for an additional 72 h at 37 1C, 5% CO2.
Addition of a 10% Formaldehyde solution was applied to the
surface of the agarose plugs for 1 h at room temperature. The
plates were then rinsed with a gentle stream of diH2O and the
agarose plugs removed. A 1% crystal violet solution was added to
each of the wells at room temperature with rocking for 30 min.
The plates were rinsed with diH2O and visible plaques were
counted to determine viral titers as PFU/mL.
Statistical analysis
Triplicate data points were averaged and mean was graphed
unless otherwise indicated. Comparisons between groups was car-
ried out using the unpaired Students t-test. P values were calculated
by the unpaired Students t-test using Excel software. Statistical
signiﬁcance was set at Po0.05 unless otherwise indicated.
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